Evidence map›Paper›PMID 29386698›Full record

ArticleDisease markers2017

Association between Two Resistin Gene Polymorphisms and Metabolic Syndrome in Jilin, Northeast China: A Case-Control Study.

Yingli Fu, Yaqin Yu, Yanhua Wu, Yueyue You, Yangyu Zhang, Changgui Kou

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 13 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yingli FuDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.ORCID 0000-0003-0455-5962
Yaqin YuDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.ORCID 0000-0002-8687-8839
Yanhua WuDivision of Clinical Epidemiology, First Hospital of Jilin University, Changchun, China.
Yueyue YouDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.
Yangyu ZhangDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.
Changgui KouDepartment of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China.ORCID 0000-0001-9544-4066
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MetS) is a significant health care problem worldwide and is characterized by increased fasting glucose and obesity. Resistin is a protein hormone produced both by adipocytes and immunocompetent cells, including those residing in adipose tissue, and is believed to modulate glucose tolerance and insulin action. This study examined the association of resistin gene polymorphisms, rs1862513 and rs3745368, and related haplotypes with the development of metabolic syndrome in a Han Chinese population. This case-control study was performed on 3792 subjects, including 1771 MetS cases and 2021 healthy controls from the Jilin province of China. Metabolic syndrome was defined according to the criteria of the International Diabetes Federation (IDF). Logistic regression analysis was used to estimate the relationship between gene polymorphism and MetS. Our results showed that there were no significant associations between MetS and the genotype distributions in four kinds of inheritance models, allele frequencies, and related haplotypes of resistin gene polymorphisms rs1862513 and rs3745368 (all

Indexed as

Polymorphism, Single NucleotideCase-Control StudiesChinaFemaleHumansMaleMetabolic SyndromeMiddle AgedResistinResistin

Identifiers

PMID29386698
PMCPMC5745751
OpenAlexW2775468047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.